SP1 and colon carcinoma: We postulate that the effects of DIG-MSK on gene transcription are mainly due to interference with the binding of Sp1 to its putative binding sites in gene promoters, yet we also observed that other transcription factors were modulated by the drug in their binding to gene promoters, in keeping with our previous observations in colon carcinoma cells [29].